Objective (OCL) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
23 Dec, 2025Executive summary
Revenue for H1 FY25 reached $61.3 million, up 6% year-over-year, with annualized recurring revenue (ARR) up 10% to $107 million and net profit after tax at $17 million, up 4% year-over-year.
Adjusted EBITDA rose 6% to $23.3 million, and cash increased 26% to $84.3 million, with no external borrowings.
84% of revenue was recurring, the highest ever, driven by the transition to subscription software and SaaS, with SaaS CAGR at 29%.
Interim unfranked dividend of 9.0 cents per share declared, payable 17 March 2025.
Strategic focus on SaaS and subscription revenue, with strong ARR growth and margins, and major customer wins in North America and the UK.
Financial highlights
Adjusted EBITDA margin exceeded 39%, with gross margin at 94% and operating margin at 32%.
R&D investment for H1 was $15.1 million, representing 30% of software revenue, with cumulative R&D since listing set to surpass $300 million by June 30.
Cash conversion ratio (operating cash flow/EBITDA) was 54%, with operating cash flow at $12.6 million.
Earnings per share rose to 17.9 cents, and net tangible assets per share increased to 37.9 cents.
No large, one-off deals impacted results, with growth spread across business lines.
Outlook and guidance
Management targets 15% ARR growth for FY2025, with H1 growth at 10% and strong early H2 momentum.
Confident in achieving full-year ARR growth target, with no reliance on a few large deals.
Expecting organic growth to accelerate in H2, especially in Planning and Building as NZ market conditions improve.
Major acceleration for 360 product line anticipated in FY26 and beyond.
M&A remains a focus, but organic growth is prioritized; smaller, strategic acquisitions possible.
Latest events from Objective
- Revenue, ARR, and profit rose double digits, fueled by SaaS growth and AI-driven innovation.OCL
H1 202626 Feb 2026 - Revenue and profit surged, driven by SaaS and ARR growth, with a strong international outlook.OCL
H2 202423 Jan 2026 - Strong growth, SaaS transition, and key approvals defined the 2024 AGM.OCL
AGM 202412 Jan 2026 - Strong recurring revenue growth, high R&D investment, and strategic AI-driven expansion highlighted.OCL
AGM 202525 Nov 2025 - ARR up 15% to AUD 120m, strong SaaS growth, and Isovist acquisition drive FY2026 outlook.OCL
H2 202523 Nov 2025